EU Approval Of Oxford/AstraZeneca COVID-19 Vaccine Expected By End Of January
AstraZeneca is expected to apply for the EU approval of its COVID-19 vaccine next week. The vaccine was developed in partnership with the University of Oxford.
You may also be interested in...
The European Medicines Agency may issue an opinion on approving AstraZeneca’s COVID-19 vaccine by 29 January if the data are robust and complete and any additional data requests are dealt with promptly.
Coronavirus Notebook: UK OKs Moderna Vaccine & Use Of Tocilizumab/Sarilumab In Hospitalized Patients
The EMA explains how to get six doses from a vial of the Pfizer/BioNTech vaccine, while the UK seems isolated in its decision to give the second dose of the vaccine 12 weeks after the first.
The first deliveries of Moderna’s COVID-19 vaccine to European countries are expected to begin next week.